NCT04921566View on ClinicalTrials.gov

Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 5, 2021

Primary Completion Date

June 20, 2021

Study Completion Date

June 20, 2021

Conditions
Bioequivalence
Interventions
DRUG

Torasemide tablet 10 mg

Torasemide is manufactured by Pharmtechnology LLC, Belarus. Each tablet contains 10 mg of torasemide.

DRUG

Toradiur® tablet 10 mg

Toradiur® is manufactured by MEDA Manufacturing Cologne, Germany. Each tablet contains 10 mg of torasemide.

Trial Locations (1)

150047

"Private healthcare institution Clinical Hospital RZD-Medicine of the city of Yaroslavl", Yaroslavl

All Listed Sponsors
collaborator

ClinPharmInvest, LLC

OTHER

lead

Pharmtechnology LLC

INDUSTRY